Fred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® on February 21-24, 2024. The ASTCT and CIBMTR tandem meetings features findings on transplantation, cell therapies, immunology and more.
You do your best to protect your skin from the sun. But did you know Mother Nature ups the ante on windy days? Our experts…
The CheckMate 9DW trial found that nivolumab and ipilimumab elicited a median OS of 23.7 months compared with 20.6 months from lenvatinib or sorafenib.
Ohio State cancer doctors are taking their expertise to Ethiopia to help prevent lymphoma through a program focused on treatment, vaccination and education.
The Chinese NMPA has approved sacituzumab tirumotecan for EGFR-mutant advanced NSCLC following progression on an EGFR TKI and chemotherapy.
Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence…
A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The approach may help some men with lower risk…
Fred Hutch is integrating a new artificial intelligence (AI) technology, GI Genius, into colonoscopy scans to help evaluate suspicious polyps.
In this issue of Blood, Li et al report their finding that the small molecule compound lasalocid A specifically targets mutated MYD88 L265P protein in diff
Using publicly available data from review documents on Drugs@FDA and information listed in FDA’s public database on post-market requirements (PMRs) Friends created this dashboard to…
During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary refractory or early relapsed DBLCL since the introduction…
